Executive Summary
Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has proved elusive, leaving the market wide open.
There are today 216 (195) companies plus partners developing 278 (209) cancer vaccine drugs in 500 (343) developmental projects in cancer. In addition, there are 6 (6) suspended drugs and the accumulated number of ceased drugs over the last years amount to another 168 (173) drugs. Cancer Vaccines Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 110 (97) different targets. These targets are further categorized on in the software application by 40 (38) classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath. Figures in brackets are comparative data from last year.
Find and sort drugs by twelve different parameters plus free text search field. Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser, whether it is a single drug profile or an entire search you want have a report of.
How May This Drug Pipeline Update Be of Use?
* Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
* Find competitors, collaborations partners, M&A candidates etc.
* Jump start competitive drug intelligence operations
* Excellent starting point for world wide benchmarking
* Compare portfolio and therapy focus with your peers
* Speed up pro-active in-/out licensing strategy work
* Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug.
Drug Pipeline Update is delivered to you as a downloadable application, which requires no installation on your computer. Please read more about application features and system requirements below.
Drug Pipeline Update at a Glance
| Investigators | Includes more than 216 (195) principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators. Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator. |
| Drug name & Synonyms | Lists commercial, generic and code names for drugs. |
| Developmental stage | This Drug Pipeline Update contains 278 (209) cancer vaccine drugs in development, which have a total of 500 (343) developmental projects in cancer. In addition there are suspended and ceased drugs. Pipeline Breakdown According to Number of Drugs Marketed# 11 (8) Registered# 1 (2) Pre-registration# 2 (1) Phase III# 22 (14) Phase II# 81 (61) Phase I# 68 (46) Preclinical# 142 (98) No Data# 2 (8) Suspended# 6 (6) Ceased# 168 (173) Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application. |
| Indications | Included cancer vaccine drugs are also in development for 79 (70) other indications, where of 50 (45) are different cancer indications. Note: You are able to find and sort drugs according to type of indication from drop-down menu in the application. |
| Targets | Identified drugs are linked to more than 110 (97) different targets, divided into 40 (38) classifications of molecular function: - Acid phosphatase activity - Carboxypeptidase activity - Catalytic activity - Cell adhesion molecule activity - Chaperone activity - Cofactor binding - Complement activity - Cytokine activity - DNA binding - DNA topoisomerase activity - DNA-directed DNA polymerase activity - Growth factor activity - Heat shock protein activity - Hormone activity - Hydrolase activity - Isomerase activity - Kinase binding - Kinase regulator activity - Metallopeptidase activity - MHC class I receptor activity - Molecular function unknown - Oxidoreductase activity - Peptidase activity - Peptide hormone - Protein binding - Protein serine/threonine kinase activity - Protein-tyrosine kinase activity - Receptor activity - Receptor binding - Receptor signaling complex scaffold activity - Receptor signaling protein serine/threonine kinase activity - RNA-directed DNA polymerase activity - Serine-type peptidase activity - T cell receptor activity - Transcription factor activity - Transcription regulator activity - Transmembrane receptor activity - Transmembrane receptor protein tyrosine kinase activity - Transporter activity - Unknown Identified targets are categorized into 22 (20) different primary and alternate sub-cellular localizations: - Apical membrane - Centrosome - Clathrin-coated vesicle - Cytoplasm - Cytoskeleton - Endoplasmic reticulum - Endosome - Extracellular - Extracellular matrix - Golgi apparatus - Integral to membrane - Lysosome - Mitochondrial matrix - Mitochondrion - n/a - Nucleolus - Nucleus - Peroxisomal matrix - Plasma membrane - Sarcoplasmic reticulum - Secreted - Secretory granule Note: You are able to find and sort drugs according to target gene name, molecular function of target, and target localization from drop-down menus in the application. |
| Target Expression Profile | Direct links are provided from inside the application to 126 (99) protein expression profiles of 81 (66) drug targets in various human tissues and cancer types, cell lines and primary cells, including up to: - 48 different normal tissue types - 20 different types of cancer - 47 cell lines - 12 samples of primary blood cells |
| Pathway Referals | Identified targets have been cross referenced against their involvement in different cellular pathways, according to BioCarta, KEGG and NetPath. - BioCarta# 118 (108) Pathways - KEGG# 85 (85) Pathways - NetPath# 16 (16) Signaling Pathways Note: You are able to find and sort drugs according to targeted pathways from drop-down menus in the application. |
| Mechanism | In total there are 79 (72) different drug mechanism of action represented in this Drug Pipeline Update. Note: You are able to find and sort drugs according to mechanism of action from drop-down menu in the application. |
| Compound | Identified drug compounds are described by: Compound type, Chemical name, CAS Number and molecular weight Note: You are able to sort and find drugs according to compound type from drop-down menu in the application. |
| Drug Profile | Progress analysis and review of drug development. A typical drug profile reports on, depending on stage of development and available information: Drug Name & Synonyms Presentation of drug name and synonyms Principal Investigator & Partners Presentation of principal investigator and partners Target and Molecular Function of Target Described target(s) is/are presented with: Official Gene Symbol – Official Gene Name [Species/Homo Sapiens] – Molecular Function Target Localization Described target(s) is/are presented with primary and alternate localizations. Target Expression Profiles Links to protein expression profile(s) of target(s) in various human tissues, cell lines and primary cells, including up to: 48 different normal tissue types 20 different types of cancer 47 cell lines 12 samples of primary blood cells Targeted Pathways Described target(s) is/are matched for the involvement in cellular pathways according to BioCarta, KEGG, and NetPath. Mechanism Drug mechanism of action Developmental Projects Summary field of developmental projects for the drug, including indication, developmental stage and status. Example: Cancer, myeloma – Phase II Clinical Trial – Active Cancer, prostate – Phase III Clinical Trial – Ceased Drug Description Short introduction to drug Compound Data Compound type, Chemical name, CAS Number and molecular weight Patent Data Available patent information related to the drug is presented here. Business & Markets Collaborations and deals Approvals and submissions Analyst comments Phase III Data Available Phase III development data, developmental history and scientific data. Phase II Data Available Phase II development data, developmental history and scientific data. Phase I Data Available Phase I development data, developmental history and scientific data. Preclinical Data Available preclinical development data, developmental history and scientific data. Licensing Information Availability for licensing |
| Application Features | Use 13 different parameters, available in drop-down menus, to find and sort among drugs - Drug status - Clinical Trial Status - Principle Investigator - Partners - Indication - Developmental Stage - Compound Type - Mechanism - Target - Molecular Function of Target - Target Localization - Targeted Pathways - Free text search of entire drug profile contents Direct linkage from inside the application to related internet resources - Drug data is linked to search engines like Google and PubMed - Drug target data is linked directly to BioCarta, Human Protein Atlas, KEGG, and NetPath - Direct links to company web pages of principal investigators Dynamic Report Generator Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser (Internet Explorer), whether it is a single drug profile or an entire search you want have a report of. |
| System Requirements | - Operating system: Windows (2000/XP/Vista/7) and Mac OS X 10.6 (Snow Leopard) and OS X 10.7 (Lion) - Browser Application (Internet Explorer) - Internet access (to access related internet resources) |
Other selected research from the 'Drugs' category:
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2011
There are today 185 companies plus partners developing 258 IL-2 pathway targeting drugs in 746 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 86 drugs. Il-2 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 116 different targets. Learn More
Antithrombotic/Anticoagulant Drugs: World Market Prospects 2010-2025
Where you can find opportunities in this market. Our new report will show you how the market for antithrombotic and anticoagulant drugs will develop. You can indentify where the greatest... Learn More
Other selected research from the 'Drug Pipeline Updates' category:
IL-6 Signaling Pathway in Oncology Drug Pipeline Update 2011
There are today 218 companies plus partners developing 292 IL-6 pathway targeting drugs in 777 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 114 drugs. Il-6 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 119 different targets. Learn More
Cytokine Therapy in Oncology Drug Pipeline Update 2011
There are today 83 (69) companies plus partners developing 104 (70) cytokine drugs in 205 (139) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 6 (5) drugs. Cytokine Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 20 (19) different targets. Learn More
Other selected research from the 'Oncology' category:
Triple Analysis: Leukemia, Pancreatic Cancer and Protein Kinase Inhibitors
This triple analysis focuses on cancer drug development strategies in both Leukemia and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More
Triple Analysis: Leukemia, Lymphoma and Angiogenesis
This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the mechanism/target/effect of Angiogenesis. Learn More
Other selected research from the 'Immunomodulators' category:
Analytical Tool - Cancer Therapeutic Antibodies
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer antibody R&D and business development. Learn More
Cytokine Therapy in Oncology Drug Pipeline Update 2011
There are today 83 (69) companies plus partners developing 104 (70) cytokine drugs in 205 (139) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 6 (5) drugs. Cytokine Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 20 (19) different targets. Learn More
Other selected research from the 'Vaccines' category:
Cancer Vaccines Fantasy or Future?
In this newly updated progress analysis, BioSeeker not only provide a solid background and information structure, we also bring the latest within cancer vaccine achievements. Learn More
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions... Learn More